Literature DB >> 15705608

Peripheral neuropathy in patients with inflammatory bowel disease.

F A A Gondim1, T H Brannagan, H W Sander, R L Chin, N Latov.   

Abstract

Peripheral neuropathy (PN) in inflammatory bowel disease (IBD) patients has been reported as individual cases or small series; however, its clinical and electrodiagnostic features have not been well characterized. We conducted a retrospective review of patients with PN and either Crohn's disease (CD) or ulcerative colitis (UC). Eighteen patients with CD and 15 patients with UC were identified after other PN causes were excluded. Male predominance and mean age of PN presentation in the fifties was seen in both groups. Demyelinating neuropathy (CIDP or MMN) occurred in close to 30% of the patients, in a higher percentage of women, than in the non-demyelinating patients. One-third of CD and UC patients had small-fibre or large-fibre sensory axonal PN, while approximately 40% of the CD and UC patients had large-fibre axonal sensorimotor PN. PN symptoms began earlier in the course of CD than in UC (P < 0.05). Patients with large-fibre axonal PN were older than patients with small-fibre sensory axonal PN (P < 0.05). Close to 60% of each group received immunotherapy with different agents. Half of those treated with CD and 40% with UC had demyelinating PN. Most of the patients who completed immunotherapy in both groups improved; all the patients with demyelinating neuropathy had either moderate or major improvement. The PN syndromes in IBD patients are diverse. Demyelinating forms may occur at any time, but early in the IBD course, pure sensory neuropathy is more common. Response to immunotherapy may occur in both demyelinating and axonal neuropathies.

Entities:  

Mesh:

Year:  2005        PMID: 15705608     DOI: 10.1093/brain/awh429

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  34 in total

1.  Isolated motor conduction block associated with infliximab.

Authors:  A W Michell; A Gaitatzis; J Burge; M M Reilly; R Kapoor; M Koltzenburg
Journal:  J Neurol       Date:  2012-02-18       Impact factor: 4.849

Review 2.  Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

Authors:  Janneke G Hoeijmakers; Catharina G Faber; Giuseppe Lauria; Ingemar S Merkies; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2012-05-29       Impact factor: 42.937

Review 3.  Pain and inflammatory bowel disease.

Authors:  Klaus Bielefeldt; Brian Davis; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

Review 4.  Peripheral neuropathy: clinical and electrophysiological considerations.

Authors:  Tae Chung; Kalpana Prasad; Thomas E Lloyd
Journal:  Neuroimaging Clin N Am       Date:  2013-05-25       Impact factor: 2.264

5.  An unusual presentation of ulcerative colitis.

Authors:  Praveen Kesav; Dheeraj Khurana
Journal:  BMJ Case Rep       Date:  2015-01-06

6.  Tubercular neuritis: A new manifestation of an ancient disease.

Authors:  Kushal Naha; Mariya Joseph Dasari; Mukhyaprana Prabhu
Journal:  Australas Med J       Date:  2011-12-31

7.  Neurologic Manifestations of Inflammatory Bowel Disease.

Authors:  Jose M Ferro
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-09

Review 8.  Inflammatory bowel disease: an increased risk factor for neurologic complications.

Authors:  Germán Morís
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 9.  Neurologic manifestations of gastrointestinal and liver diseases.

Authors:  José M Ferro; Sofia Oliveira
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

Review 10.  Neurological disorders and inflammatory bowel diseases.

Authors:  Giovanni Casella; Gian Eugenio Tontini; Gabrio Bassotti; Luca Pastorelli; Vincenzo Villanacci; Luisa Spina; Vittorio Baldini; Maurizio Vecchi
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.